QR code

Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Aim. To assess the efficacy of FLAG/FLAG-Ida regimen and to identify factors that influence remission, duration of disease-free survival (DFS) and overall survival (OS) of patients with relapsed/refractory acute myeloid leukemia (AML). Materials & Methods. The trial included 54 patients (28 men a...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Irina Garmaevna Budaeva, E. G. Ovsyannikova, E. N. Goryunova, O. V. Kulemina, D. V. Zaitsev, D. V. Motorin, R. Sh. Badaev, D. B. Zammoeva, V. V. Ivanov, K. V. Bogdanov, O. S. Pisotskaya, Yu. V. Mirolyubova, T. S. Nikulina, Yu. A. Alekseeva, A. Yu. Zaritskey, L. L. Girshova
Formaat: Artigo
Taal:Russo
Gepubliceerd in: Practical Medicine Publishing House 2019-07-01
Reeks:Клиническая онкогематология
Onderwerpen:
acute myeloid leukemia
relapse
refractoriness
flag and flag-ida regimens
Online toegang:https://bloodjournal.ru/index.php/coh/article/view/323
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items